DOSE-RANGING AND DOSE-SETTING FOR INVIVO GENETIC TOXICOLOGY STUDIES

被引：0
|
作者：
MACKAY, LM [1 ]
ELLIOTT, BM [1 ]
机构：
[1] ICI CENT TOXICOL LAB,MACCLESFIELD,ENGLAND
来源：
MUTATION RESEARCH | 1993年 / 291卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：254 / 254
页数：1
相关论文
共 50 条
  • [31] SIBUTRAMINE DOSE-RANGING, EFFICACY STUDY IN OBESITY
    WEINTRAUB, M
    RUBIO, A
    GOLIK, A
    BYRNE, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 172 - 172
  • [32] DOSE-RANGING STUDIES OF MEGLUMINE IODAMIDE, A NEW CONTRAST AGENT FOR EXCRETORY UROGRAPHY
    MCKINSTRY, DN
    DIFAZIO, LT
    VUKOVICH, RA
    CLINICAL RESEARCH, 1976, 24 (03): : A511 - A511
  • [33] The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies
    Zohar, S
    Chevret, S
    STATISTICS IN MEDICINE, 2001, 20 (19) : 2827 - 2843
  • [34] Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation
    Springer, Michael J.
    Ni, Yawei
    Finger-Baker, Isaac
    Ball, Jordan P.
    Hahn, Jessica
    DiMarco, Ashley V.
    Kobs, Dean
    Horne, Bobbi
    Talton, James D.
    Cobb, Ronald R.
    VACCINE, 2016, 34 (12) : 1452 - 1458
  • [35] Beyond exposure-response: A tutorial on statistical considerations in dose-ranging studies
    Laird, Glen
    Xu, Lei
    Liu, Meng
    Liu, Jin
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1250 - 1258
  • [36] Needed: Improved Dose Selection in Genetic Toxicology Studies
    Pottenger, Lynn H.
    Price, Paul S.
    Gollapudi, B. Bhaskar
    HUMAN AND ECOLOGICAL RISK ASSESSMENT, 2012, 18 (01): : 4 - 12
  • [37] Using a dose-finding benchmark to quantify the loss incurred by dichotomization in Phase II dose-ranging studies
    Mozgunov, Pavel
    Jaki, Thomas
    Paoletti, Xavier
    Mozgunov, Pavel (p.mozgunov@lancaster.ac.uk), 1717, Wiley-VCH Verlag (62): : 1717 - 1729
  • [38] A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens
    Jordan, SD
    Poole, CJ
    Archer, VR
    Steven, NM
    Burton, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 113 - 118
  • [39] Dose-ranging design and analysis methods to identify the minimum effective dose (MED)
    Zhou, Yijie
    Chen, Su
    Sullivan, Danielle
    Li, Yihan
    Zhang, Ying
    Xie, Wangang
    Zhang, Hongtao
    Tang, Yuanyuan
    Wang, Li
    Hartford, Alan
    Yang, Bo
    CONTEMPORARY CLINICAL TRIALS, 2017, 63 : 59 - 66
  • [40] A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens
    Sarah D. Jordan
    Christopher J. Poole
    Venice R. Archer
    Neil M. Steven
    Andrea Burton
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 113 - 118
12345